标题/作者	年份
Medication treatment for opioid use disorders in substance use treatment facilities R Mojtabai, C Mauro, MM Wall, CL Barry, M Olfson Health Affairs 38 (1), 14-23	2019
Changing trends in opioid overdose deaths and prescription opioid receipt among veterans LA Lin, T Peltzman, JF McCarthy, EM Oliva, JA Trafton, ASB Bohnert American journal of preventive medicine 57 (1), 106-110	2019
Article Commentary: Stepped Care for Opioid Use Disorder Train the Trainer (Scoutt) Initiative: Expanding Access to Medication Treatment for Opioid Use Disorder within Veterans Health Administration Facilities AJ Gordon, K Drexler, EJ Hawkins, J Burden, NK Codell, A Mhatre-Owens, ... Substance Abuse 41 (3), 275-282	2020
Availability of medications for the treatment of alcohol and opioid use disorder in the USA AJ Abraham, CM Andrews, SJ Harris, PD Friedmann Neurotherapeutics 17, 55-69	2020
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration LA Lin, ASB Bohnert, FC Blow, AJ Gordon, RV Ignacio, HM Kim, MA Ilgen Addiction 116 (1), 96-104	2021
Differences in availability and use of medications for opioid use disorder in residential treatment settings in the United States AS Huhn, JG Hobelmann, JC Strickland, GA Oyler, CL Bergeria, ... JAMA network open 3 (2), e1920843-e1920843	2020
Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine N Brunet, DT Moore, D Lendvai Wischik, KM Mattocks, MI Rosen Substance Abuse 43 (1), 39-46	2022
Medication treatment for opioid use disorder and community pharmacy: expanding care during a national epidemic and global pandemic G Cochran, J Bruneau, N Cox, AJ Gordon Substance abuse 41 (3), 269-274	2020
No end to the crisis without an end to the waiver JW Frank, SE Wakeman, AJ Gordon Substance Abuse 39 (3), 263-265	2018
Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities H Hagedorn, M Kenny, AJ Gordon, PE Ackland, S Noorbaloochi, W Yu, ... Addiction science & clinical practice 13, 1-9	2018
Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration H Valenstein-Mah, H Hagedorn, CL Kay, ML Christopher, AJ Gordon Substance abuse 39 (3), 286-288	2018
Security and privacy of patient information in medical systems based on blockchain technology H Wu, AD Dwivedi, G Srivastava ACM Transactions on Multimedia Computing, Communications, and Applications …	2021
Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a chart verification study BA Howell, EA Abel, D Park, SN Edmond, LJ Leisch, WC Becker Journal of general internal medicine 36, 1264-1270	2021
Opioid agonist therapy during hospitalization within the Veterans Health Administration: a pragmatic retrospective cohort analysis KC Priest, TI Lovejoy, H Englander, S Shull, D McCarty Journal of general internal medicine 35, 2365-2374	2020
Disparities in access to medications for opioid use disorder in the Veterans Health Administration AK Finlay, AHS Harris, C Timko, M Yu, D Smelson, M Stimmel, ... Journal of addiction medicine 15 (2), 143	2021
Identifying individuals with opioid use disorder: validity of International Classification of Diseases diagnostic codes for opioid use, dependence and abuse P Lagisetty, C Garpestad, A Larkin, C Macleod, D Antoku, S Slat, ... Drug and alcohol dependence 221, 108583	2021
Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what? A Manhapra, E Stefanovics, R Rosenheck Substance abuse 41 (1), 110-120	2020
Predictors of timely opioid agonist treatment initiation among veterans with and without HIV JJ Wyse, JL Robbins, KA McGinnis, EJ Edelman, AJ Gordon, A Manhapra, ... Drug and Alcohol Dependence 198, 70-75	2019
Article Commentary: It Will End in Tiers: A Strategy to Include “Dabblers” in the Buprenorphine Workforce after the X-Waiver B Saloner, B Andraka Christou, AJ Gordon, BD Stein Substance Abuse 42 (2), 153-157	2021
Telehealth utilization is associated with lower risk of discontinuation of buprenorphine: a retrospective cohort study of US veterans JP Vakkalanka, BC Lund, MM Ward, S Arndt, RW Field, M Charlton, ... Journal of general internal medicine 37 (7), 1610-1618	2022

1 - 20

计算机程序会自动估算并确定日期和引用次数。